Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

HIV vaccine trial tests new Prime-Boost strategy

NCT ID NCT05470400

First seen Apr 30, 2026 · Last updated May 22, 2026 · Updated 3 times

Summary

This early-stage study tested whether new HIV vaccines are safe and can trigger an immune response in healthy adults. Researchers gave different combinations of vaccines to 44 participants to see how well they were tolerated. The study was terminated early, so results are limited.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Atlanta - Hope Clinic

    Atlanta, Georgia, 30308, United States

  • BIDMC Vcrs [32077]

    Boston, Massachusetts, 02115, United States

  • Columbia P&S CRS [30329]

    New York, New York, 30329, United States

  • New York Blood Center CRS [31801]

    New York, New York, 10065, United States

  • University of Pittsburgh CRS [1001]

    Pittsburgh, Pennsylvania, 15213, United States

  • University of Rochester Vaccines to Prevent HIV Infection CRS [31467]

    Rochester, New York, 14642, United States

Conditions

Explore the condition pages connected to this study.